Marker Therapeutics, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Marker Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Marker Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -90.2 %, a 73% decline year-over-year.
  • Marker Therapeutics, Inc. annual Return On Equity for 2023 was -50.1 %, a 55.6% increase from 2022.
  • Marker Therapeutics, Inc. annual Return On Equity for 2022 was -113 %, a 56.5% decline from 2021.
  • Marker Therapeutics, Inc. annual Return On Equity for 2021 was -72.2 %, a 17% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -50.1 +62.9 +55.6% Jan 1, 2023 Dec 31, 2023
2022 -113 -40.8 -56.5% Jan 1, 2022 Dec 31, 2022
2021 -72.2 +14.8 +17% Jan 1, 2021 Dec 31, 2021
2020 -87 -43.9 -102% Jan 1, 2020 Dec 31, 2020
2019 -43.1 +870 +95.3% Jan 1, 2019 Dec 31, 2019
2018 -913 -716 -364% Jan 1, 2018 Dec 31, 2018
2017 -197 -228 -729% Jan 1, 2017 Dec 31, 2017
2016 31.3 -77.2 -71.1% Jan 1, 2016 Dec 31, 2016
2015 109 -1.16K -91.4% Jan 1, 2015 Dec 31, 2015
2014 1.27K Jan 1, 2014 Dec 31, 2014
2012 132 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.